| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 0.969 | 388 | 0 | 1985 | 2020 | ||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
disease | 0.400 | None | 0.961 | 77 | 0 | 1995 | 2020 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.400 | None | 0.935 | 62 | 0 | 1990 | 2020 | |||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1992 | 2020 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1992 | 2020 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.100 | None | 0.925 | 40 | 0 | 1986 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 32 | 0 | 1992 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 19 | 0 | 2010 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1998 | 2020 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.100 | None | 0.846 | 13 | 0 | 2003 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1990 | 2015 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2014 | 2019 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 2011 | 2019 | ||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1992 | 2019 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1992 | 2019 | |||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1985 | 2017 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2011 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 1992 | 2019 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
disease | 0.090 | None | 0.667 | 9 | 0 | 2000 | 2019 | ||||||||
|
lysine methyltransferase 2D | 0.465 | 0.808 | 1.00 |
|
disease | 0.380 | None | 1.000 | 9 | 0 | 2011 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2014 | 2019 | ||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1991 | 2019 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 | ||||||||
|
TNF receptor superfamily member 14 | 0.568 | 0.731 | 0.81 |
|
disease | 0.370 | None | 1.000 | 7 | 0 | 2010 | 2017 |